271 related articles for article (PubMed ID: 25218961)
21. Astrocyte overexpression of heme oxygenase-1 improves outcome after intracerebral hemorrhage.
Chen-Roetling J; Song W; Schipper HM; Regan CS; Regan RF
Stroke; 2015 Apr; 46(4):1093-8. PubMed ID: 25690543
[TBL] [Abstract][Full Text] [Related]
22. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
23. Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment.
Song W; Cressatti M; Zukor H; Liberman A; Galindez C; Schipper HM
Neurobiol Aging; 2017 Oct; 58():163-179. PubMed ID: 28746897
[TBL] [Abstract][Full Text] [Related]
24. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
[TBL] [Abstract][Full Text] [Related]
25. The sinister face of heme oxygenase-1 in brain aging and disease.
Schipper HM; Song W; Tavitian A; Cressatti M
Prog Neurobiol; 2019 Jan; 172():40-70. PubMed ID: 30009872
[TBL] [Abstract][Full Text] [Related]
26. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
27. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
28. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
Pappolla MA; Chyan YJ; Omar RA; Hsiao K; Perry G; Smith MA; Bozner P
Am J Pathol; 1998 Apr; 152(4):871-7. PubMed ID: 9546346
[TBL] [Abstract][Full Text] [Related]
29. Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.
Di Domenico F; Pupo G; Mancuso C; Barone E; Paolini F; Arena A; Blarzino C; Schmitt FA; Head E; Butterfield DA; Perluigi M
J Alzheimers Dis; 2015; 44(4):1107-20. PubMed ID: 25391381
[TBL] [Abstract][Full Text] [Related]
30. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
31. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
[TBL] [Abstract][Full Text] [Related]
32. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
33. HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues.
Zukor H; Song W; Liberman A; Mui J; Vali H; Fillebeen C; Pantopoulos K; Wu TD; Guerquin-Kern JL; Schipper HM
J Neurochem; 2009 May; 109(3):776-91. PubMed ID: 19250338
[TBL] [Abstract][Full Text] [Related]
34. Glial HMOX1 expression promotes central and peripheral α-synuclein dysregulation and pathogenicity in parkinsonian mice.
Cressatti M; Song W; Turk AZ; Garabed LR; Benchaya JA; Galindez C; Liberman A; Schipper HM
Glia; 2019 Sep; 67(9):1730-1744. PubMed ID: 31180611
[TBL] [Abstract][Full Text] [Related]
35. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
[TBL] [Abstract][Full Text] [Related]
36. Heme oxygenase-1 modulates microRNA expression in cultured astroglia: implications for chronic brain disorders.
Lin SH; Song W; Cressatti M; Zukor H; Wang E; Schipper HM
Glia; 2015 Jul; 63(7):1270-84. PubMed ID: 25820186
[TBL] [Abstract][Full Text] [Related]
37. IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer's Disease.
Escrig A; Molinero A; Méndez B; Giralt M; Comes G; Sanchis P; Fernández-Gayol O; Giménez-Llort L; Becker-Pauly C; Rose-John S; Hidalgo J
Cells; 2020 Jul; 9(7):. PubMed ID: 32630818
[TBL] [Abstract][Full Text] [Related]
38. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.
González de San Román E; Llorente-Ovejero A; Martínez-Gardeazabal J; Moreno-Rodríguez M; Giménez-Llort L; Manuel I; Rodríguez-Puertas R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830150
[TBL] [Abstract][Full Text] [Related]
39. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD.
Schipper HM; Gupta A; Szarek WA
Curr Alzheimer Res; 2009 Oct; 6(5):424-30. PubMed ID: 19874266
[TBL] [Abstract][Full Text] [Related]
40. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.
Kamphuis W; Mamber C; Moeton M; Kooijman L; Sluijs JA; Jansen AH; Verveer M; de Groot LR; Smith VD; Rangarajan S; Rodríguez JJ; Orre M; Hol EM
PLoS One; 2012; 7(8):e42823. PubMed ID: 22912745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
